In conclusion, a total of 3 genes associated with the development of dermatomyositis—MX2, OAS1, and OAS2—were identified in this study through a series of information biology analyses, which are expected to be biomarkers or drug targets to some extent for the diagnosis of dermatomyositis. The gene discussed is OAS2; the disease is dermatomyositis.